An Improved Version Of Egrifta An HGH Analog Has Been Approved By The FDA

“The new formulation offers several advantages over the currently marketed two-vial formulation. This will definitely help to support growth in the coming months and years,” added Mr. Tanguay.


EGRIFTA® is currently approved in the United States, Canada, and Mexico.

Contraindications to take EGRIFTA®

• Pituitary gland disorders
Cancer/ undergoing cancer therapy
• Allergic to tesamorelin
• Pregnant women
• Children less than 18 years of age.

The most common side effects of EGRIFTA® :

1. Joint pain
2. Pain in legs and arms
3. Swelling in your legs
4. Muscle pain
5. Tingling, numbness, and pricking
6. Nausea and vomiting

Related Article:



One Response


Want to Stay Informed?

Join the Gilmore Health News Newsletter!

Want to live your best life?

Get the Gilmore Health Weekly newsletter for health tips, wellness updates and more.

By clicking "Subscribe," I agree to the Gilmore Health and . I also agree to receive emails from Gilmore Health and I understand that I may opt out of Gilmore Health subscriptions at any time.